General Information of Drug Inactive Ingredient (DIG) (ID: E00132)

DIG Name
Acrylic acid
Synonyms
ACRYLIC ACID; 2-Propenoic acid; Propenoic acid; 79-10-7; prop-2-enoic acid; Vinylformic acid; Acroleic acid; Propene acid; Ethylenecarboxylic acid; Polyacrylate; POLYACRYLIC ACID; Propenoate; Carbomer; Glacial acrylic acid; Acrylic acid, glacial; Kyselina akrylova; Carbopol 934p; RCRA waste number U008; Acrylic polymer; Carbomer 940; Carbopol 940; 9003-01-4; Acrylic acid, polymer; Carbopol; Acrylic resin; Aron; Antiprex A; UNII-J94PBK7X8S; NSC 4765; Versicol E9; Acrylic acid resin; Acrysol ase-75; Acrysol lmw-20X; Versicol E 7; Versicol E15; Acrysol A 1; Acrysol A 3; Acrysol A 5; Acrysol AC 5; 2-Propenoic acid, homopolymer; Carbopol 960; Carboset 515; Primal Ase 60; Versicol K 11; Versicol S 25; Viscalex HV 30; Dispex C40; Acrysol WS-24; Cyguard 266; Joncryl 678; Jurimer AC 10H; Jurimer AC 10P; Nalfloc 636; Rohagit SD 15; Carboxy vinyl polymer; Good-rite K 37; Revacryl A 191; Dow Latex 354; Junlon 110; Propenoic acid polymer; Viscon 103; Good-rite K 702; Good-rite K 732; Polyacrylate elastomers; Acrylic acid, polymers; Good-rite WS 801; Acrylic acid homopolymer; Polymerized acrylic acid; Synthemul 90-588; Aron A 10H; Atactic poly(acrylic acid); Carboset Resin No. 515; J94PBK7X8S; OLD 01; PA 11M; PAA-25; CHEBI:18308; NSC4765; Carboxypolymethylene; P 11H; P-11H; WS 24; C3:1n-1; Acrysol A-1; Revacryl A191; MFCD00004367; WS 801; 25987-55-7; NCGC00166246-01; R968; Carbopol CV 940; Caswell No. 009A; Acrylates; Acide acrylique; Acido acrilio; Phytogel base; Acido acrilio [Spanish]; Acide acrylique [French]; Synthalen K; Kyselina akrylova [Czech]; Calcium polyacrylate; XPA; Acritamer 940; CCRIS 737; Acrylic acid, 98%, extra pure, stabilized; HSDB 1421; EINECS 201-177-9; Acrylic acid homopolymer calcium salt; UN2218; RCRA waste no. U008; allenediol; BRN 0635743; UNII-4Q93RCW27E; Carbomerum; Carbomere; Carbomero; Carpolene; Texcryl; Arolon; Racryl; Tecpol; Carbomer 940 [USAN:NF]; Acrylic Resins; AI3-15717; Solidokoll N; 2-Propenoic acid, homopolymer, calcium salt; Poly(acrylamide), granular, non-ionic, approx. M.W. 5 to 6.000.000; Poly(acrylic acid), 25 wt% solution in water; approx. M.W. 240,000; Poly(acrylic acid), 50 wt% solution in water, approx. M.W. 5,000; Poly(acrylic acid), 63 wt% solution in water; approx. M.W. 2,000; Sokalan PAS; acrylic acid group; Poly(acrylic acid), sec. stand., aver. MW 1,080,000, aver. MN 135,000; G-Cure; Pemulen TR-1; Pemulen TR-2; Acrylic acid polymer; Antiprex 461; Carbomer 910; Carbomer 934P; Carbopol 910; Carbopol 961; Carbopol 980; Haloflex 202; Haloflex 208; Arasorb 750; Polytex 973; Good-rite K727; 29862-29-1; 76050-42-5; Acrylic polymer resins; Arasorb S 100F; Carbopol(R) 940; Good-rite K-700; Polymer, carboxy vinyl; Colloids 119/50; Neocryl A-1038; PubChem21090; Acrylic acid, inhibited; ACMC-1CHHZ; CH2=CHCOOH; DSSTox_CID_28; Carbomer 934 (NF); Carbomer 940 (NF); Carbomer 941 (NF); Carbomere [INN-French]; Carbomerum [INN-Latin]; Carbopol 910 (TN); Carbopol 934 (TN); Carbopol 940 (TN); Carbopol 941 (TN); Carboxypolymethylene resin; UNII-K6MOM3T5YL; Carbomero [INN-Spanish]; Carbomer 934P (NF); Carbopol 934P (TN); 2-Hydroxyethyl methacrylate vinyl acetate 2-ethylhexyl acrylate polymer; K6MOM3T5YL; Carbomer 910 (USAN); Carbomer 934 [USAN]; Carbomer 940 [USAN]; Carbomer 1342 (NF); Carbomer 934p [USAN]; Carbopol 1342 (TN); UNII-59TL3WG5CO; UNII-9G2MAD7J6W; UNII-D0I6NSZ87U; UNII-F68VH75CJC; UNII-HHT01ZNK31; UNII-U990QE4LKP; EC 201-177-9; 59TL3WG5CO; 9G2MAD7J6W; D0I6NSZ87U; DSSTox_RID_79425; F68VH75CJC; HHT01ZNK31; U990QE4LKP; UNII-0A5MM307FC; UNII-1N11AG4X4L; UNII-KD3S7H73D3; WLN: QV1U1; DSSTox_GSID_39229; 2-Propenic acid, homopolymer; Polyacrylic acid calcium salt; 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, polymer with ethenyl acetate and 2-ethylhexyl 2-propenoate; 4-02-00-01455 (Beilstein Handbook Reference); OC(O)=C=C; UN 2218 (Salt/Mix); Acrylic acid, p.a., 99%; UNII-132584PQMO; UNII-71DD5V995L; UNII-A8371R0U5J; Carbomer 910 [USAN:NF]; 0A5MM307FC; 1N11AG4X4L; 4Q93RCW27E; CCRIS 3234; KD3S7H73D3; CHEMBL1213529; DTXSID0039229; UNII-73861X4K5F; UNII-809Y72KV36; UNII-Z135WT9208; HSDB 7826; 132584PQMO; 71DD5V995L; A8371R0U5J; ZINC895281; NSC-4765; STR00040; Tox21_112372; 7023AF; ANW-43674; LMFA01030193; NSC106034; NSC106035; NSC106036; NSC106037; NSC112122; NSC112123; NSC114472; NSC165257; NSC226569; STL281870; 1-$l^{1}-oxidanylprop-2-en-1-one; AKOS000118799; 73861X4K5F; 809Y72KV36; DB02579; MCULE-9352227082; NSC 106034; NSC 106035; NSC 106036; NSC 106037; NSC 112122; NSC 112123; NSC 114472; NSC 165257; NSC-106034; NSC-106035; NSC-106036; NSC-106037; NSC-112122; NSC-112123; NSC-114472; NSC-165257; NSC-226569; TB 1131; Z135WT9208; CAS-79-10-7; Polymer of acrylic acid, cross-linked with allyl ethers of sucrose or pentaerythritol; BP-30259; A0141; FT-0621875; FT-0660730; 1312-EP2270113A1; 1312-EP2272935A1; 1312-EP2275469A1; 1312-EP2287940A1; 1312-EP2289965A1; 1312-EP2298753A1; 1312-EP2305033A1; 1312-EP2308857A1; 1312-EP2308861A1; 1312-EP2308865A1; 1312-EP2308882A1; 1312-EP2374784A1; 1312-EP2374785A1; 1313-EP2272537A2; 1313-EP2289894A2; 1313-EP2298743A1; 1313-EP2308833A2; 1313-EP2311840A1; 1313-EP2371811A2; 1313-EP2374787A1; 2186-EP2277879A1; 2186-EP2305636A1; 2186-EP2311821A1; 2186-EP2374787A1; 3854-EP2270113A1; 3854-EP2272849A1; 3854-EP2272935A1; 3854-EP2275414A1; 3854-EP2275418A1; 3854-EP2277565A2; 3854-EP2277566A2; 3854-EP2277567A1; 3854-EP2277568A2; 3854-EP2277569A2; 3854-EP2277570A2; 3854-EP2289879A1; 3854-EP2292280A1; 3854-EP2298753A1; 3854-EP2302003A1; 3854-EP2305219A1; 3854-EP2305683A1; 3854-EP2305684A1; 3854-EP2308857A1; 3854-EP2308858A1; 3854-EP2309584A1; 3854-EP2311816A1; 3854-EP2311817A1; 3854-EP2311831A1; 3854-EP2311839A1; 3854-EP2311840A1; 3854-EP2314589A1; 3854-EP2315303A1; 3854-EP2316837A1; 3854-EP2371803A1; 3854-EP2372017A1; 3854-EP2374538A1; 3854-EP2374786A1; 3854-EP2377842A1; 3854-EP2377843A1; 3854-EP2377847A1; C00511; C19501; D03392; D03393; D03394; D03395; D03396; D03397; Acrylic Acid contains 200ppm MEHQ as inhibitor; Acrylic acid, inhibited [UN2218] [Corrosive]; A830860; Q324628; Z57127944; F0001-2070; 2-Propenoic acid, block polymer with sulfonated ethenylbenzene; Acrylic acid, anhydrous, contains 200 ppm MEHQ as inhibitor, 99%; Polymer of 2-propenoic acid, cross-linked with allyl ethers of sucrose; Polymer of acrylic acid, cross-linked with allyl ethers of pentaerythritol; Polymer von linksdrehender acrylsaeure mit einem polyfunktionalen agens; Acrylic acid, SAJ first grade, >=97.0%, contains 190-210 ppm MEHQ as stabilizer; Block copolymer of sulfonated polystyrene and polyacrylic acid (MW 250,000); Polymer of 2-propenoic acid, cross-linked with allyl ethers of pentaerythritol; Polymer of 2-propenoic acid, cross-linked with allyl ethers of sucrose or pentaerythritol; 55927-87-2; Polymer of acrylic acid, cross-linked with allyl ethers of pentaerythritol. Molecular weight is approximately 1,250,000; Polymer of acrylic acid, cross-linked with allyl ethers of pentaerythritol. Molecular weight is approximately 750,000; Polymer of acrylic acid, cross-linked with allyl ethers of sucrose or pentaerythritol. Molecular weight is approximately 3,000,000; Polymer of acrylic acid, cross-linked with allyl ethers of sucrose. Molecular weight is approximately 3,000,000
DIG Function
Other agent
Formula
C3H4O2
Canonical SMILES
C=CC(=O)O
InChI
1S/C3H4O2/c1-2-3(4)5/h2H,1H2,(H,4,5)
InChIKey
NIXOWILDQLNWCW-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 72.06 Topological Polar Surface Area 37.3
XlogP 0.3 Complexity 55.9
Heavy Atom Count 5 Rotatable Bond Count 1
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 2

Full List of Drug(s) Co-administrated with This DIG

5 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Adapalene DMX2358 Acne vulgaris [ED80] Adapalene 0.3% gel F24250
Aspirin DM672AH Myocardial infarction [BA41-BA43] Aspirin 325 mg tablet F01592
Benzyl alcohol DMBVYDI Head and body lice [1G00.0] Benzyl Alcohol 5% lotion F23084
Betaxolol DM6EUL5 Hypertension [BA00-BA04] Betaxolol Hydrochloride eq 0.25% base suspension F23382
Desoximetasone DM4PXF6 Inflammation [1A00-CA43.1] Desoximetasone 0.05% gel F23706
------------------
1 Investigative Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Oxybutynine DMJPBAX Discovery agent [N.A.] Oxybutynin 3.9mg extended release film F23502
------------------